November 05, 2024 13:30 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pakistan's Lahore has become world's most polluted city with an AQI of 1900 on Sunday | Indian Army 'successfully completes' patrolling to a key point in Ladakh's Depsang region | US presidential election: Donald Trump ahead of Kamala Harris in swing states, poll survey predicts | 'I strongly condemn Hindu temple attack, intimidation of our diplomats': PM Modi amid Canada row | 'I strongly condemn Hindu temple attack, intimidation of our diplomats': PM Modi amid Canada row

PM Modi, Mamata Banerjee, Adar Poonawalla feature in TIME's 100 most influential people's list

New Delhi/IBNS: Prime Minister Narendra Modi and West Bengal Chief Minister Mamata Banerjee have featured in TIME Magazine's list of 100 most influential people for the year 2021.

Hope to resolve soon: SII CEO Adar Poonawalla on Covishield-vaccinated Indians facing EU travel issues

Pune/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he hopes to resolve the issues which Covishield-vaccinated Indians, who are planning to travel to Europe, are facing.

'Never exported vaccines at the cost of people of India': Adar Poonawalla

Pune/IBNS: Adar Poonawalla, CEO of Serum Institute of India (SII), the manufacturer of Covishield, on Tuesday said that his company has "never exported vaccines at the cost of the people of India".

Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses

New Delhi/IBNS: Adar Poonawalla, the CEO of Serum Institute of India (SII) that manufactures anti-Covid-19 vaccine Covishield, has welcomed the central government's decision to increase the gap between the first and second doses of the vaccine to 12-16 weeks.

My comments have been misinterpreted: Adar Poonawalla clarifies on interview with UK media

London/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Monday said his comments made last week to British newspaper The Times, in which he spoke about "aggressive" phone calls from influential people in India demanding an increased production of Covishield vaccine, have been "misinterpreted".

Aggression over Covid vaccines overwhelming, says Adar Poonawalla hinting to start producing in Britain

London: Amid India's catastrophic Covid19 crisis and demand for vaccines, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said he was under pressure and aggression over vaccines is overwhelming. He also hinted at starting production outside India in a country like Britain.

Serum Insititute chief Adar Poonwalla to get 'Y-category' security cover

New Delhi/IBNS: Pune-based Serum Institute of India's chief Adar Poonawalla will be provided with 'Y-category' security across the country, media reports said.

Opposition targets Modi govt over 'vaccine discrimination' after Serum Institute announces Covishield prices

New Delhi/IBNS: Mounting pressure further on the Centre, several opposition leaders have criticised the Narendra Modi government over the difference in prices at which the Serum Institute of India (SII) has decided to sell its Covid-19 vaccine to the Centre, states and private hospitals.

Bangladesh requests India to expedite delivery of Covishield

New Delhi/Dhaka/IBNS: The Bangladesh government has requested India to speed up the delivery of 500,000 doses of Covid-19 vaccines to ensure that its immunization programme is not affected.

'Believe Rs 3,000 cr govt aid will reach us soon, didn't wait but borrowed': SII CEO Adar Poonawalla

Mumbai/IBNS: Serum Institute of India (SII) has borrowed money from banks to ramp up the production of Covishield instead of waiting for the government's aid of Rs 3,000 crore to arrive.

Adar Poonawalla thanks PM Modi for decisive 'policy changes and swift financial aid' amid vaccine shortage

Mumbai/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla has lauded the Centre's policy change in vaccination, bringing all above 18 under the mass drive and extending financial support to the vaccine manufacturers.

AstraZeneca sends legal notice to Serum Institute over delays in vaccine supply

New Delhi/IBNS: Serum Institute of India (SII) has been served a legal notice by AstraZeneca over vaccine supply delays, a Business Standard report said.

Serum Institute seeks financial assistance from govt to boost capacity

New Delhi/IBNS: Adar Poonawalla, the CEO of world's largest vaccine manufacturer Serum Institute of India (SII), has told NDTV it needs Rs 3,000 crore in assistance from the Indian government to expand its production capacity which is currently "very stretched" in wake of the export restrictions imposed by the government last month.

Production of Covishield is on schedule, remains unaffected by fire tragedy: Serum Institute CEO Adar Poonawalla

Pune: A day after a massive fire hit vaccine-maker Serum Institute of India's Pune facility, company's CEO Adar Poonawalla on Friday assured the production of Covishield, the vaccine meant to fight against COVID-19, is on schedule and remains unaffected by the tragedy.

Covid-19 vaccination drive: Serum Institute of India CEO Adar Poonawalla gets inoculated

Pune/IBNS: Joining the crores of health workers, Serum Institute of India (SII) CEO Adar Poonwalla got himself inoculated with Covid-19 vaccine made by his own pharmaceutical company.